Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
Montes de Oca
Rocio
R
Dana-Farber Cancer Institute, Department of Radiation Oncology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA.
Andreassen
Paul R
PR
Margossian
Steven P
SP
Gregory
Richard C
RC
Taniguchi
Toshiyasu
T
Wang
Xiaozhe
X
Houghtaling
Scott
S
Grompe
Markus
M
D'Andrea
Alan D
AD
D002453:Cell Cycle / Q000187:drug effects; D002478:Cells, Cultured; D002843:Chromatin / Q000235:genetics*; D004249:DNA Damage / Q000235:genetics; D004260:DNA Repair / Q000235:genetics; D005199:Fanconi Anemia / Q000235:genetics*; D052236:Fanconi Anemia Complementation Group D2 Protein; D014644:Genetic Variation; D006367:HeLa Cells; D006801:Humans; D008856:Microscopy, Fluorescence; D016685:Mitomycin / Q000494:pharmacology; D009687:Nuclear Proteins / Q000235:genetics*; D011485:Protein Binding; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics; D017384:Sequence Deletion; D025801:Ubiquitin / Q000378:metabolism
D002843:Chromatin; C499905:FANCD2 protein, human; D052236:Fanconi Anemia Complementation Group D2 Protein; D009687:Nuclear Proteins; D012333:RNA, Messenger; D025801:Ubiquitin; D016685:Mitomycin